Regulatory Science Ireland: bridging the information gap on biosimilar medicines
Loading...
Files
Accepted Version
Date
2016-10-31
Authors
O'Callaghan, Joan
Barry, Sean P.
Moore, Una
Bermingham, Margaret
Morris, J. Michael
Hallinan, Frank
Griffin, Brendan T.
Journal Title
Journal ISSN
Volume Title
Publisher
Pro Pharma Communications International
Published Version
Abstract
Regulatory Science Ireland (RSI) is a voluntary network of interested parties from academia, the Health Products Regulatory Authority (HPRA), pharmaceutical and medical device industries and government agencies. RSI is conducting a research project, the objective of which is to enhance understanding of biosimilar medicines amongst stakeholders and encourage best practice in the use of these medicines.
Description
Keywords
Biological medicines , Biosimilar , Health Products Regulatory Authority , Regulatory science , Regulatory Science Ireland
Citation
O'Callaghan, J., Barry, S., Moore, U., Bermingham, M., Morris, J. M., Hallinan, F. and Griffin, B. T. (2016) 'Regulatory Science Ireland: Bridging the information gap on biosimilar medicines', GaBI Journal, 5(4), pp. 168-170. doi:10.5639/gabij.2016.0504.043
Collections
Copyright
© 2016 Pro Pharma Communications International. The original publication is available at www.gabi-journal.net